WeVote
Log In

Bill

Bill

A 3852

Establishes Psilocybin behavioral Health Access and Therapy Pilot Program; appropriates $6 million.*

2024-2025 Regular Session Introduced by Clinton Calabrese and 4 co-sponsors

New Jersey funds $6M pilot program to study psilocybin's therapeutic use for behavioral health under controlled medical supervision, advancing research into Schedule I substance treatment.

Reported out of Senate Committee with Amendments and Referred to Assembly Appropriations Committee
#health
0
WeVote Research Nonpartisan
Bill Summary · A 3852

Legislative bill overview

Bill A 3852 establishes a pilot program in New Jersey to study the therapeutic use of psilocybin (a psychoactive compound found in certain mushrooms) for behavioral health treatment. The bill appropriates $6 million to fund clinical research, training, and controlled therapeutic administration of psilocybin under medical supervision.

Why is this important

Psilocybin research has shown promise in treating depression, PTSD, and end-of-life anxiety in clinical settings, yet it remains federally classified as a Schedule I controlled substance, severely limiting research. This pilot program would make New Jersey one of the first states to formally study therapeutic psilocybin use within a structured medical framework, potentially influencing national drug policy and mental health treatment options.

Potential points of contention

  • Federal-state legal conflict: Psilocybin remains illegal under federal law; the state program could face legal challenges or federal enforcement complications despite state authorization
  • Public safety concerns: Opponents may worry about drug diversion, misuse potential, or normalizing controlled substance access without sufficient safety data from the pilot
  • Cost-benefit questions: Critics may challenge whether $6 million is an appropriate allocation for an experimental program with uncertain outcomes compared to other mental health funding priorities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.